These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 7847836)

  • 41. Proliferative activity of primary breast cancer and of synchronous lymph node metastases evaluated by [3H]-thymidine labelling index.
    Daidone MG; Silvestrini R; Valentinis B; Persici P; Mezzanotte G; Squicciarini P; Orefice S; Salvadori B
    Cell Tissue Kinet; 1990 Sep; 23(5):401-8. PubMed ID: 2245439
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Changes in cell kinetics induced by primary chemotherapy in breast cancer.
    Daidone MG; Silvestrini R; Valentinis B; Ferrari L; Bartoli C
    Int J Cancer; 1991 Feb; 47(3):380-3. PubMed ID: 1993544
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Feasibility and reproducibility of the [3H]-thymidine labelling index in breast cancer. The SICCAB Group for Quality Control of Cell Kinetic Determination.
    Silvestrini R
    Cell Prolif; 1991 Sep; 24(5):437-45. PubMed ID: 1932355
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 3H-thymidine labelling index (TLI) as a marker of tumour growth heterogeneity: evaluation in human solid carcinomas.
    Becciolini A; Balzi M; Barbarisi M; Faraoni P; Biggeri A; Potten CS
    Cell Prolif; 1997; 30(3-4):117-26. PubMed ID: 9375024
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relationship between cytosol TPS, TPA and cell proliferation.
    Gion M; Mione R; Becciolini A; Balzi M; Correale M; Piffanelli A; Giovannini G; Saccani Jotti G; Fontanesi M
    Int J Biol Markers; 1994; 9(2):109-14. PubMed ID: 7930761
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term prognostic significance of thymidine labelling index in primary breast cancer.
    Cooke TG; Stanton PD; Winstanley J; Murray GD; Croton R; Holt S; George WD
    Eur J Cancer; 1992; 28(2-3):424-6. PubMed ID: 1591056
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Utilization of the TLI technic (thymidine labeling index) in cancerology].
    Pasteels JL; Kiss R; Paridaens R
    Rev Med Liege; 1987 Mar; 42(5):167-73. PubMed ID: 3576021
    [No Abstract]   [Full Text] [Related]  

  • 48. Iododeoxyuridine labelling of S-phase fraction in fine needle aspirates from breast carcinomas.
    Maas RA; Bruning PF; Breedijk AJ; Peterse JL
    J Clin Pathol; 1996 Jul; 49(7):607-9. PubMed ID: 8813968
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tritiated thymidine labelling in vitro of human cancer of the breast: counting error and sampling error.
    Lambert M
    Eur J Cancer Clin Oncol; 1986 Jul; 22(7):781-5. PubMed ID: 3770036
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The proliferative patterns of human breast cancer cells in vivo.
    Post J; Sklarew RJ; Hoffman J
    Cancer; 1977 Apr; 39(4):1500-7. PubMed ID: 851943
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Use of the TLI (thymidine labelling index) technic in cancerology].
    Pasteels JL; Kiss R; Paridaens R
    Rev Med Brux; 1987 Mar; 8(3):111-6. PubMed ID: 3589258
    [No Abstract]   [Full Text] [Related]  

  • 52. Multiple oblique illumination and high-definition microscopy for breast fine-needle aspirates.
    Puc MM; Chrzanowski FA; Tran H; Geldziler B; Martucci M; Doolin EJ; Hewitt CW
    J Invest Surg; 2000; 13(5):259-63. PubMed ID: 11071561
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The cell cycle kinetics of human breast cancer.
    Straus MJ; Moran RE
    Cancer; 1980 Dec; 46(12):2634-9. PubMed ID: 7448702
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cell kinetics and biochemical parameters in breast cancer.
    Becciolini A; Porciani S; Balzi M; Lanini A; Scubla E; Pacini P; Benucci A; Distante V
    Int J Biol Markers; 1992; 7(1):16-20. PubMed ID: 1583346
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Acid and neutral mucopolysaccharides in breast cancer].
    Ovanesbekova TG
    Zh Eksp Klin Med; 1975; 15(4):68-71. PubMed ID: 128267
    [No Abstract]   [Full Text] [Related]  

  • 56. Feasibility of thymidine labelling index on fine needle aspirates from breast cancer: comparison with surgical samples.
    Barbieri F; Parodi G; Massa T; Cagnoli M; Barbi G; Imperiale A; Alama A
    Anticancer Res; 1994; 14(5A):1973-7. PubMed ID: 7847836
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Single cell multiple biomarker analysis in archival breast fine-needle aspiration specimens: quantitative fluorescence image analysis of DNA content, p53, and G-actin as breast cancer biomarkers.
    Rao JY; Apple SK; Hemstreet GP; Jin Y; Nieberg RK
    Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1027-33. PubMed ID: 9829712
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison between Ki-67 index and S-phase fraction on fine-needle aspiration samples from breast carcinoma.
    Bozzetti C; Nizzoli R; Camisa R; Guazzi A; Ceci G; Cocconi G; Mazzini G; Naldi N
    Cancer; 1997 Oct; 81(5):287-92. PubMed ID: 9349516
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Breast carcinomas with immunocytochemical detection of aromatase in fine-needle aspirates: report of three cases.
    Tsunoda Y; Shimizu Y; Tsunoda A; Kamiya K; Kusano M; Takimoto M
    Hum Pathol; 2001 Mar; 32(3):348-51. PubMed ID: 11274648
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Specimen adequacy and false-negative diagnosis rate in fine-needle aspirates of palpable breast masses.
    Boerner S; Sneige N
    Cancer; 1998 Dec; 84(6):344-8. PubMed ID: 9915135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.